CN Patent

CN119136806A — 用于治疗免疫难治性肺癌的方法

Assigned to Ruixin Pharmaceutical Co · Expires 2024-12-13 · 1y expired

What this patent protects

本公开提供了用于使用RAS抑制剂治疗免疫难治性肺癌的方法。本公开还提拱了用于治疗免疫难治性肺癌的组合疗法。

USPTO Abstract

本公开提供了用于使用RAS抑制剂治疗免疫难治性肺癌的方法。本公开还提拱了用于治疗免疫难治性肺癌的组合疗法。

Drugs covered by this patent

Patent Metadata

Patent number
CN119136806A
Jurisdiction
CN
Classification
—
Expires
2024-12-13
Drug substance claim
No
Drug product claim
No
Assignee
Ruixin Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.